HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperglycemic damage to mitochondrial membranes during cerebral ischemia: amelioration by platelet-activating factor antagonist BN 50739.

Abstract
The Pulsinelli-Brierley four-vessel occlusion model was used to study the consequences of hyperglycemic ischemia and reperfusion. Rats were subjected to either 30 min of normo- or hyperglycemic ischemia or 30 min of normo- or hyperglycemic ischemia followed by 60 min of reperfusion. In some animals, 2 mg/kg BN 50739, a platelet-activating factor receptor antagonist, was administered intraarterially either before or after the ischemic insult. The changes in mitochondrial membrane free fatty acid levels, phosphatidylcholine fatty acyl composition, and thiobarbituric acid-reactive material (TBAR) content plus the mitochondrial respiratory control ratio (RCR) were monitored. When the platelet-activating factor antagonist was present during normoglycemia, (a) the mitochondrial free fatty acid release both during and after ischemia was slowed, (b) reacylation of phosphatidylcholine following ischemia was promoted, and (c) TBAR accumulation during and following ischemia was decreased. The detrimental effects of hyperglycemia were muted when BN 50739 was present during ischemia. The RCR was preserved and phosphatidylcholine hydrolysis during ischemia was decreased. TBAR levels were consistently higher in hyperglycemic brain mitochondria both during and after ischemia. The RCR correlated directly with mitochondrial phosphatidylcholine polyunsaturated fatty acid content during ischemia and reperfusion. BN 50739 protection of mitochondrial membranes in brain may be influenced by tissue pH.
AuthorsD B Kintner, J H Fitzpatrick Jr, D D Gilboe
JournalJournal of neurochemistry (J Neurochem) Vol. 69 Issue 3 Pg. 1219-27 (Sep 1997) ISSN: 0022-3042 [Print] England
PMID9282946 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Azepines
  • Fatty Acids, Nonesterified
  • Fatty Acids, Unsaturated
  • Membrane Lipids
  • Phospholipids
  • Platelet Activating Factor
  • Thiobarbituric Acid Reactive Substances
  • Triazoles
  • BN 50739
Topics
  • Animals
  • Azepines (pharmacology)
  • Blood Pressure
  • Brain (metabolism, pathology, physiopathology)
  • Disease Models, Animal
  • Electroencephalography (drug effects)
  • Fatty Acids, Nonesterified (metabolism)
  • Fatty Acids, Unsaturated (metabolism)
  • Femoral Artery
  • Hyperglycemia (metabolism, pathology, physiopathology)
  • Intracellular Membranes (drug effects, metabolism, pathology)
  • Ischemic Attack, Transient (metabolism, pathology, physiopathology)
  • Lipid Peroxidation (drug effects)
  • Male
  • Membrane Lipids (metabolism)
  • Mitochondria (drug effects, metabolism, pathology)
  • Oxygen Consumption (drug effects)
  • Phospholipids (metabolism)
  • Platelet Activating Factor (antagonists & inhibitors)
  • Rats
  • Rats, Sprague-Dawley
  • Reference Values
  • Reperfusion
  • Thiobarbituric Acid Reactive Substances (analysis)
  • Time Factors
  • Triazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: